At the end of each week, the law firm d’Oliveira & Associates compiles a summary of recalls, FDA warnings, market withdrawals and safety alerts that the public should be aware of for their …
At the end of each week, the law firm d’Oliveira & Associates compiles a summary of recalls, FDA warnings, market withdrawals and safety alerts that the public should be aware of for their …
The product, Vigabatrin for oral solution, USP 500mg, is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older.
Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level.